Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
33%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 3Large-scale testing
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Completed1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (50.0%)
Phase 31 (50.0%)

Trials by Status

completed133%
not_yet_recruiting133%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_2

Allopurinol in Depression

NCT07574060
completed

Sertraline and the Risk of Serious Adverse Events

NCT07387120
unknownphase_3

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

NCT06025474

Clinical Trials (3)

Showing 3 of 3 trials
NCT07574060Phase 2

Allopurinol in Depression

Not Yet Recruiting
NCT07387120

Sertraline and the Risk of Serious Adverse Events

Completed
NCT06025474Phase 3

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3